Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents

Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents

Background: The emergence and spread of SARS-CoV-2 throughout the world has created an enormous socioeconomic impact. Although there are several promising drug candidates in clinical trials, none is available clinically. Thus, the drug repurposing approach may help to overcome the current pandemic....

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Z. Ahmed (Author), Qamar Zia (Author), Anzarul Haque (Author), Ali S. Alqahtani (Author), Omar M. Almarfadi (Author), Saeed Banawas (Author), Mohammed S. Alqahtani (Author), Keshav L. Ameta (Author), Shafiul Haque (Author)
Format: Book
Published: Elsevier, 2021-05-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items